Compare Dr. Reddys with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs CIPLA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB CIPLA DR. REDDYS LAB/
CIPLA
 
P/E (TTM) x 46.6 32.3 144.4% View Chart
P/BV x 5.7 4.9 116.1% View Chart
Dividend Yield % 0.5 0.4 112.6%  

Financials

 DR. REDDYS LAB   CIPLA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
CIPLA
Mar-20
DR. REDDYS LAB/
CIPLA
5-Yr Chart
Click to enlarge
High Rs3,363586 574.4%   
Low Rs2,352357 659.2%   
Sales per share (Unadj.) Rs1,054.2212.5 496.1%  
Earnings per share (Unadj.) Rs118.519.2 617.8%  
Cash flow per share (Unadj.) Rs188.532.8 574.3%  
Dividends per share (Unadj.) Rs25.004.00 625.0%  
Dividend yield (eoy) %0.90.8 103.1%  
Book value per share (Unadj.) Rs932.5194.9 478.6%  
Shares outstanding (eoy) m166.17806.24 20.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.72.2 122.3%   
Avg P/E ratio x24.124.6 98.2%  
P/CF ratio (eoy) x15.214.4 105.6%  
Price / Book Value ratio x3.12.4 126.7%  
Dividend payout %21.120.8 101.2%   
Avg Mkt Cap Rs m474,837379,858 125.0%   
No. of employees `000NANA-   
Total wages/salary Rs m33,80230,270 111.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m175,170171,320 102.2%  
Other income Rs m6,2063,694 168.0%   
Total revenues Rs m181,376175,014 103.6%   
Gross profit Rs m24,70431,061 79.5%  
Depreciation Rs m11,63111,000 105.7%   
Interest Rs m9831,974 49.8%   
Profit before tax Rs m18,29621,782 84.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,4036,312 -22.2%   
Profit after tax Rs m19,69915,470 127.3%  
Gross profit margin %14.118.1 77.8%  
Effective tax rate %-7.729.0 -26.5%   
Net profit margin %11.29.0 124.5%  
BALANCE SHEET DATA
Current assets Rs m125,991117,062 107.6%   
Current liabilities Rs m72,14143,931 164.2%   
Net working cap to sales %30.742.7 72.0%  
Current ratio x1.72.7 65.5%  
Inventory Days Days7150 141.1%  
Debtors Days Days1058 1,263.7%  
Net fixed assets Rs m94,063117,166 80.3%   
Share capital Rs m8311,613 51.5%   
"Free" reserves Rs m154,119155,487 99.1%   
Net worth Rs m154,950157,100 98.6%   
Long term debt Rs m1,30423,693 5.5%   
Total assets Rs m220,054234,228 93.9%  
Interest coverage x19.612.0 162.9%   
Debt to equity ratio x00.2 5.6%  
Sales to assets ratio x0.80.7 108.8%   
Return on assets %9.47.4 126.2%  
Return on equity %12.79.8 129.1%  
Return on capital %12.313.1 93.9%  
Exports to sales %48.132.2 149.2%   
Imports to sales %22.63.4 656.4%   
Exports (fob) Rs m84,19355,175 152.6%   
Imports (cif) Rs m39,6165,903 671.2%   
Fx inflow Rs m84,19356,036 150.2%   
Fx outflow Rs m39,6165,903 671.2%   
Net fx Rs m44,57750,133 88.9%   
CASH FLOW
From Operations Rs m29,84130,685 97.3%  
From Investments Rs m-4,9231,040 -473.2%  
From Financial Activity Rs m-25,159-29,488 85.3%  
Net Cashflow Rs m-2662,340 -11.4%  

Share Holding

Indian Promoters % 26.7 15.0 178.3%  
Foreign collaborators % 0.0 21.7 -  
Indian inst/Mut Fund % 43.9 40.4 108.7%  
FIIs % 29.0 23.3 124.9%  
ADR/GDR % 12.2 0.0 -  
Free float % 61.0 63.3 96.4%  
Shareholders   221,107 364,796 60.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   GUFIC BIOSCIENCE  BACIL PHARMA  IOL CHEMICALS & PHARM.  FDC  BAFNA PHARMA  

Compare DR. REDDYS LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Hindalco & Hero MotoCorp Top Gainers(09:30 am)

Asian share markets are steady today after reassuring comments on inflation and monetary policy from Federal Reserve officials bolstered investor sentiment.

Related Views on News

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY21); Net Profit Up 21.4% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (4QFY20); Net Profit Down 35.1% (Quarterly Result Update)

May 19, 2020 | Updated on May 19, 2020

For the quarter ended March 2020, CIPLA has posted a net profit of Rs 2 bn (down 35.1% YoY). Sales on the other hand came in at Rs 44 bn (down 0.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (3QFY20); Net Profit Up 9.4% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, CIPLA has posted a net profit of Rs 4 bn (up 9.4% YoY). Sales on the other hand came in at Rs 44 bn (up 9.1% YoY). Read on for a complete analysis of CIPLA's quarterly results.

More Views on News

Most Popular

My 'Unlock' Investments(Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth(Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

Cut the Noise and Hold these Stocks FOREVER(Profit Hunter)

Jun 17, 2021

A sure shot way of creating wealth is to not disturb the process of compounding.

Wednesday's Market Fall Explained(Fast Profits Daily)

Jun 10, 2021

This is why the stock market fell the way it did on Wednesday.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jun 23, 2021 11:27 AM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS